Akcie - Fundamenty - Všechna data pro vaši analýzu

Nástroje

Akciový screener

Kalendář zisků

Super investoři

Ostatní

Návod

IČ: 19940963

5. května 521, 501 01 Turnov

Zásady GDPR

Podmínky služby

Všechna práva vyhrazena @ 2024, Fundamenty.cz

Proudly created by draftspot.net

Avadel Pharmaceuticals plc

AVDL

Valuace

100

Růst

Zdraví

Cena

$ 18.72

0.00 (0.00%)

Souhrn

Výkazy

Ukazatele

Profil

Držitelé

Návštěvnost webu

Konkurence

Zprávy společnosti

Kapitalizace

1.8B

Obrat

Zisk

Aktiva

Dluh

ROE

-0%

ROA

-0%

-7883

Cena 1R

6-24

⌀ Cena

14.24

Dividenda

0.0(0.0%)

Čtvrtletní 10-Q

Celoroční 10-K

Nadcházející oznámení zisků

02-03-2026

Poslední dividenda

Profil

Avadel Pharmaceuticals plc působí jako biofarmaceutická společnost ve Spojených státech. Jeho hlavním kandidátem je FT218, léková forma oxybutyrátu sodného, která je součástí klinické studie fáze 3 pro léčbu nadměrné denní ospalosti a kataplexie u dospělých s narkolepsií. Společnost byla dříve známá jako Flamel Technologies SA a v lednu 2017 změnila svůj název na Avadel Pharmaceuticals plc. Avadel Pharmaceuticals plc byla založena v roce 2015 a má sídlo v Dublinu v Irsku.

Sektor

Healthcare

Odvětví

Drug Manufacturers - Specialty & Generic

Počet zaměstnanců

188

Založení

1996-06-07

Adresa

10 Earlsfort Terrace

CEO

Gregory J. Divis Jr.

Web

www.avadel.com

Podobné společnosti

PAHC

Phibro Animal Health Corporation

$ 45.01

+ $ 1.25

ANIP

ANI Pharmaceuticals, Inc.

$ 89.13

- $ 1.30

ALVO

Alvotech

$ 5.55

- $ 0.17

OGN

Organon & Co.

$ 7.39

+ $ 0.61

TLRY

Tilray Brands, Inc.

$ 1.27

+ $ 0.03

Pediatrix Medical Group, Inc.

$ 22.44

+ $ 0.51

QDEL

QuidelOrtho Corporation

$ 20.96

+ $ 0.61

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Rozvaha

Peněžní toky

V miliónech (USD)

Revenue	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Revenues	248.5	169.1	28.0	0.0	0.0	22.3	59.2	103.3	172.7	150.2	173.2	14.8	22.4	26.1	32.6	37.1
Cost of Revenues	13.8	15.3	0.8	0.0	0.0	5.7	12.1	17.5	16.3	13.2	10.9	3.4	4.3	5.9	6.3	6.9
Gross Profit	234.8	153.8	27.1	0.0	0.0	16.6	47.1	85.8	156.4	137.0	162.3	11.4	18.1	20.2	26.3	30.2

Revenue	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Revenues	77.5	68.1	52.5	50.4	50.0	41.5	27.2	19.5	7.0	1.5
Cost of Revenues	-3.0	6.4	5.6	4.8	6.2	2.8	1.5	0.7	0.1	0.0
Gross Profit	80.5	61.8	46.9	45.6	43.9	38.7	25.7	18.8	6.9	1.5

Operating Income	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
R&D Expenses	0.0	0.0	13.3	20.7	17.1	20.4	32.9	39.3	34.2	34.6	25.6	17.3	26.7	26.1	25.1	28.7
Selling General & Admin Expenses	0.0	0.0	151.7	74.5	68.5	32.4	30.2	100.4	58.9	44.2	21.7	15.7	13.3	14.2	10.8	11.3
Depreciation & Amortization	3.7	2.7	1.8	4.8	1.0	5.1	2.5	7.4	4.9	14.5	13.1	14.1	3.1	3.2	3.3	4.7
Total Operating Expenses	230.2	196.2	165.0	95.2	85.6	53.3	63.9	146.3	96.7	92.7	59.9	44.7	40.0	40.3	35.9	40.0
Operating Income	4.5	-42.4	-137.8	-98.6	-85.5	-36.7	-16.8	-104.9	88.3	-5.0	71.4	-93.9	-50.0	-3.5	-9.6	-9.8

Operating Income	TTM	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
R&D Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.8	4.2
Selling General & Admin Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	39.2	46.8
Depreciation & Amortization	1.1	1.1	0.8	0.7	1.0	0.4	0.5	0.0	0.6	0.6
Total Operating Expenses	78.5	52.9	49.9	48.9	44.2	51.5	51.7	43.7	42.0	51.0
Operating Income	1.9	8.9	-3.0	-3.3	-0.3	-12.7	-26.0	-24.9	-35.1	-49.5

Net Income	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Interest Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.6	0.7	0.5
Interest Expense	9.7	10.8	9.9	12.3	9.9	13.0	12.5	10.6	1.1	1.0	6.3	9.3	4.3	0.1	0.1	0.0
Other Expense	-7.8	-6.7	-22.9	-12.9	-7.6	31.6	-21.8	-42.0	32.8	-53.1	-17.7	-48.7	-27.9	16.5	0.4	0.6
IBT	-3.3	-49.1	-160.8	-111.4	-93.1	-5.1	-38.6	-113.2	91.5	-9.7	78.4	-90.3	-54.1	-7.9	-8.6	-8.8
Income Tax Expense	-3.0	-0.2	-0.5	26.0	-15.8	-12.1	-5.4	-17.9	24.2	31.6	37.7	-1.4	-11.2	-4.7	0.2	0.2
Net Income	-0.3	-48.8	-160.3	-137.5	-77.3	7.0	-33.2	-95.3	67.3	-41.3	40.7	-84.9	-42.9	-3.2	-8.8	-9.0

Net Income	TTM	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Interest Income	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7
Interest Expense	2.4	2.4	2.2	2.7	2.8	2.7	2.6	2.4	2.0	2.3
Other Expense	-1.9	-2.4	-1.8	-1.7	-2.2	-1.6	-1.2	-4.0	-1.1	-14.8
IBT	0.1	6.5	-4.8	-5.0	-2.5	-14.3	-27.2	-28.9	-36.2	-64.3
Income Tax Expense	0.0	-3.2	0.1	0.1	0.1	-0.5	0.1	-0.1	0.1	0.1
Net Income	0.0	9.7	-4.9	-5.0	-2.6	-13.8	-27.3	-28.8	-36.3	-64.4

Per Share Data	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
EPS	$0.00	$0.00	$-2.00	$-2.29	$-1.32	$0.13	$-0.89	$-2.55	$1.66	$-1.00	$1.00	$-2.34	$-1.69	$-0.13	$-0.36	$-0.37
EPS Diluted	$0.00	$0.00	$-2.00	$-2.29	$-1.32	$0.13	$-0.89	$-2.55	$1.61	$-1.00	$0.93	$-2.34	$-1.69	$-0.13	$-0.36	$-0.37
Shares Outstanding	97.1	95.1	80.2	60.1	58.5	53.0	37.4	37.3	40.5	41.2	40.6	36.2	25.4	25.1	24.7	24.4
Diluted Shares Outstanding	101.3	95.1	80.2	60.1	58.5	54.9	37.4	37.3	41.8	41.2	43.6	36.2	25.4	25.1	24.7	24.4

Per Share Data	TTM	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
EPS	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.30	$-0.41	$-0.83
EPS Diluted	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$-0.30	$-0.41	$-0.83
Shares Outstanding	97.1	96.7	96.6	96.4	96.3	96.2	91.7	95.0	89.4	77.2
Diluted Shares Outstanding	101.3	99.1	96.6	96.4	96.3	96.2	91.7	95.0	89.4	77.2

Current Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Cash And Equivalents	28.8	51.4	31.2	74.0	50.7	71.7	9.8	9.3	16.6	39.2	65.1	39.8	6.6	2.7	3.5	8.2
Short Term Investments	42.5	22.4	73.9	22.5	106.5	149.7	54.4	90.6	77.5	115.0	79.7	53.1	0.4	6.4	21.0	23.2
Total Cash & ST Investments	71.4	73.8	105.1	96.5	157.2	221.4	64.2	99.9	94.1	154.2	144.8	92.8	7.0	9.2	24.5	31.3
Accounts Receivable	34.3	34.1	13.4	2.2	2.4	3.3	10.4	13.9	14.8	17.8	9.4	8.7	21.0	13.1	7.8	9.8
Inventory	13.3	20.3	10.4	0.0	0.0	0.0	3.6	4.8	6.2	3.3	4.2	6.7	3.8	1.5	1.7	0.9
Other Current Assets	6.8	6.0	5.3	2.1	32.8	38.7	4.3	0.8	9.0	5.9	8.0	0.0	0.1	0.1	2.6	3.4
Total Current Assets	125.8	134.2	134.2	100.8	192.5	263.5	82.4	124.9	124.0	181.2	166.3	112.3	33.6	25.1	36.7	45.4

Current Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Cash And Equivalents	79.8	63.4	56.4	51.4	28.6	28.8	35.8	31.2	51.8	50.0
Short Term Investments	11.8	18.1	10.1	22.4	37.2	42.5	53.0	73.9	101.4	110.5
Total Cash & ST Investments	91.6	81.5	66.5	73.8	65.8	71.4	88.8	105.1	153.2	160.5
Accounts Receivable	42.4	40.6	41.6	34.1	37.1	34.3	24.0	13.4	6.2	1.8
Inventory	23.9	23.5	20.4	20.3	16.1	13.3	11.9	10.4	5.3	1.4
Other Current Assets	14.3	13.4	10.8	6.0	8.3	6.8	11.3	5.3	7.6	7.5
Total Current Assets	172.2	159.1	139.3	134.2	127.3	125.8	136.0	134.2	172.3	171.2

Long-Term Assets	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Property, Plant & Equipment	2.6	12.9	3.2	2.6	2.9	3.0	4.2	7.8	3.0	3.3	2.6	1.8	17.4	18.2	19.4	21.4
Goodwill	16.8	16.8	16.8	16.8	16.8	16.8	18.5	18.5	18.5	18.5	18.5	18.5	18.5	18.5	0.0	0.0
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.6	92.3	22.8	15.8	28.4	40.1	41.6	0.0	0.0
Long-Term Investments	0.3	0.0	0.0	0.0	-22.9	-14.8	-23.1	8.7	1.4	1.8	0.0	0.0	0.0	0.0	0.2	0.0
Other Long-Term Assets	12.0	0.3	10.5	12.6	33.8	24.9	39.3	5.7	9.1	7.5	0.2	0.1	6.6	13.9	13.2	7.8
Total Long-Term Assets	31.7	30.0	30.5	31.9	54.8	48.2	69.1	65.4	128.2	64.3	48.7	61.9	82.6	92.2	32.8	29.3
Total Assets	157.5	164.2	164.7	132.8	247.3	311.6	151.4	190.3	252.1	245.5	215.0	174.2	116.3	117.3	69.4	74.6

Long-Term Assets	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Property, Plant & Equipment	3.0	11.0	11.7	12.9	13.8	14.5	14.5	3.2	3.5	2.0
Goodwill	16.8	16.8	16.8	16.8	16.8	16.8	16.8	16.8	16.8	16.8
Intangible Assets	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Long-Term Investments	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4
Other Long-Term Assets	7.4	0.2	0.2	0.3	0.4	0.4	0.6	10.2	10.6	11.0
Total Long-Term Assets	27.2	28.1	28.7	30.0	31.0	31.7	31.9	126.9	30.8	29.7
Total Assets	199.4	187.2	167.9	164.2	158.3	157.5	167.9	261.1	203.1	201.0

Current Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Accounts Payable	9.8	7.3	11.4	7.9	7.7	2.9	6.1	3.5	7.5	7.1	10.6	8.0	5.1	3.6	3.9	4.9
Short-Term Debt	0.9	0.6	1.9	38.6	0.9	0.5	0.6	0.1	0.1	0.3	0.4	42.3	19.3	3.4	2.1	2.4
Other Current Liabilities	34.0	40.9	23.6	9.3	5.3	5.2	3.9	34.7	76.6	52.8	32.7	19.1	14.8	6.1	7.5	9.6
Current Liabilities	44.6	48.8	36.9	55.8	21.0	15.1	36.0	38.4	86.2	62.4	48.8	70.8	40.6	14.4	18.3	19.4

Current Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Accounts Payable	12.6	10.1	9.1	7.3	7.9	9.8	19.0	11.4	13.3	11.8
Short-Term Debt	0.7	0.7	0.7	0.6	0.7	0.9	1.0	1.9	23.0	22.4
Other Current Liabilities	49.2	46.2	41.1	40.9	34.1	34.0	27.9	23.6	17.8	17.3
Current Liabilities	62.5	57.1	50.9	48.8	42.8	44.6	47.8	36.9	54.1	51.5

Long-Term Liabilities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Long-Term Debt	35.5	1.1	34.4	92.4	144.1	130.1	124.0	115.7	0.2	0.5	0.7	76.1	66.4	33.5	1.9	1.7
Capital Leases	1.3	1.7	2.6	1.7	2.6	2.3	3.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.2
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.3	134.3	1.4	0.0	8.9	26.8	0.0	0.0
Total Liabilities	87.2	90.4	77.0	153.9	169.0	149.4	180.6	187.5	167.5	203.4	147.1	149.3	125.8	86.8	39.6	38.3

Long-Term Liabilities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Long-Term Debt	36.6	2.0	2.2	1.1	1.2	1.3	1.4	34.5	1.9	0.5
Capital Leases	0.0	2.7	2.9	1.7	1.9	2.2	2.4	1.7	2.8	1.3
Def. Tax Liability	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	5.5	5.4
Total Liabilities	101.2	96.4	93.9	90.4	83.6	87.2	89.5	173.4	93.0	57.8

Total Common Equity	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Common Stock	1.0	1.0	0.9	0.6	0.6	0.6	0.4	0.4	0.4	0.4	6.3	6.2	3.7	3.7	3.6	3.6
Retained Earnings	-786.7	-794.3	-745.5	-585.2	-447.8	-384.2	-391.2	-358.0	-263.7	-319.8	-279.8	-320.5	-235.5	-192.6	-189.4	-180.6
Comprehensive Income	-24.2	-24.6	-23.2	-26.3	-23.9	-21.1	-22.8	-23.4	-23.3	-23.6	-22.7	-7.4	10.8	10.3	10.1	10.9
Total Common Equity	70.3	73.8	87.7	-21.1	78.2	162.3	-29.2	2.8	84.6	42.1	67.9	24.9	-9.5	30.5	29.8	36.3

Total Common Equity	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Common Stock	1.0	1.0	1.0	1.0	1.0	1.0	1.0	0.9	0.9	0.9
Retained Earnings	-789.6	-789.6	-799.2	-794.3	-789.3	-786.7	-772.8	-745.5	-716.7	-680.4
Comprehensive Income	-23.6	-23.6	-24.3	-24.6	-23.8	-24.2	-23.8	-23.2	-26.0	-25.9
Total Common Equity	98.2	90.7	74.1	73.8	74.7	70.3	78.4	87.7	110.1	143.2

Other		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Total Debt		37.7	1.7	35.4	131.0	145.0	130.5	124.7	115.8	0.3	0.8	1.1	118.5	85.7	36.9	4.1	4.1
Book Value		70.3	73.8	87.7	-21.1	78.2	162.3	-29.2	2.8	84.6	42.1	67.9	24.9	-9.5	30.5	29.8	36.3

Other		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Total Debt		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Book Value		98.2	90.7	74.1	73.8	74.7	70.3	78.4	87.7	110.1	143.2

Cash Flow From Operating Activities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Income	-106.2	-48.8	-160.3	-137.5	-77.3	7.0	-33.2	-95.3	67.3	-41.3	40.7	-84.9	-42.9	-3.2	-8.8	-9.0
Depreciation & Amortization	1.6	2.7	1.8	1.5	0.8	1.7	2.5	7.4	4.9	14.5	13.1	14.1	3.1	3.2	3.3	4.7
Stock-Based Compensation	17.5	20.4	15.8	7.0	8.9	3.0	0.5	7.9	8.1	14.7	7.7	2.7	2.0	3.0	2.8	3.2
Change Working Capital	-27.3	-20.3	-3.0	24.5	3.7	-8.1	2.3	-11.7	2.4	1.3	-4.8	8.2	-1.7	-8.7	-4.4	-3.3
Change In Accounts Receivable	-31.1	-22.0	-10.2	0.0	0.0	8.3	2.5	3.5	3.1	-10.1	-8.1	3.4	-0.5	2.6	-0.5	0.7
Change In Accounts Payable	-2.6	-4.1	1.5	-3.1	4.2	-2.8	4.6	-2.0	0.6	-0.4	-3.9	1.1	1.3	-0.6	-0.8	-0.5
Change In Inventories	-10.3	-9.2	-9.5	0.0	0.0	-1.4	1.2	0.7	-2.9	1.8	2.5	-3.1	-2.2	0.2	-0.9	0.2
Other Non-cash Items	53.8	-0.8	17.2	8.1	2.3	-44.9	-4.0	28.2	-69.5	33.7	26.2	52.0	30.2	-12.7	-8.8	3.2
Cash from Operations	-114.0	0.0	-128.5	-70.3	-77.3	-48.7	-38.3	-82.7	16.7	18.9	84.3	-10.6	-20.7	-23.1	-10.3	-5.5

Cash Flow From Operating Activities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Income	0.0	9.7	-4.9	-5.0	-2.6	-13.8	-27.3	-28.8	-36.3	-64.4
Depreciation & Amortization	1.1	1.1	0.8	0.7	1.0	0.4	0.5	0.0	0.6	0.6
Stock-Based Compensation	0.0	5.3	4.2	4.1	5.4	5.5	5.4	3.5	3.1	7.6
Change Working Capital	-3.8	-2.5	-8.4	7.9	-10.9	-9.8	-7.6	-4.4	-5.6	10.4
Change In Accounts Receivable	-1.9	1.0	-7.5	3.0	-3.7	-10.7	-10.6	-5.9	-4.5	0.4
Change In Accounts Payable	2.4	1.0	1.8	-0.6	-1.9	-9.2	7.5	-2.3	1.4	2.0
Change In Inventories	-0.7	-3.3	-0.1	-4.0	-3.0	-1.0	-1.3	-4.2	-3.8	-1.4
Other Non-cash Items	26.0	-0.9	0.1	0.2	0.2	-0.5	-0.7	17.5	-0.1	0.6
Cash from Operations	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-28.0	-38.2	-32.0

Cash Flow From Investing Activities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Capital Expenditure	0.0	0.0	0.0	-0.7	0.0	-0.1	0.0	-20.2	-53.7	-1.2	-1.6	-1.7	-1.0	-1.1	-1.9	-3.6
Acquisitions	0.0	0.0	0.0	0.0	16.5	25.5	0.0	20.0	53.1	0.6	0.8	0.0	0.0	1.8	0.0	0.0
Investments	-299.0	-276.0	-237.2	-3.4	-61.8	-131.4	-24.6	-376.3	-151.0	-107.6	-50.6	-68.3	-1.1	-3.6	-25.0	-73.6
Sales of Investment	368.5	327.8	187.1	83.8	102.2	36.3	63.2	359.5	189.0	71.5	20.5	13.7	7.2	18.2	26.4	83.1
Other Investing Activities	41.8	0.0	0.0	0.0	0.0	0.0	0.2	-20.0	-53.1	0.0	-0.8	13.2	1.0	0.1	0.2	0.1
Cash from Investing	69.6	0.0	-50.1	79.7	56.9	-69.7	38.7	-37.0	-15.7	-36.6	-31.7	-43.1	6.0	15.4	-0.4	6.0

Cash Flow From Investing Activities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Capital Expenditure	0.0	-0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Acquisitions	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Investments	-5.8	-36.2	-5.5	-14.0	-86.1	-78.2	-97.7	-33.7	-90.1	-103.2
Sales of Investment	12.7	28.1	17.8	29.0	91.0	88.8	119.1	61.6	99.9	10.3
Other Investing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	-92.9
Cash from Investing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	9.8	-92.9

Cash Flow From Financing Activities	TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Debt Repaid	-51.4	0.0	-38.7	-8.7	0.0	0.0	0.0	0.0	0.0	0.0	-4.9	-34.6	-0.6	-0.3	-2.0	0.0
Debt Issued	66.9	-33.7	-57.0	-5.3	14.5	5.9	8.8	115.6	-0.5	-0.3	-112.5	67.3	49.4	33.1	2.0	4.1
Issuance of Common Stock	12.5	0.0	146.1	25.3	0.3	179.7	0.1	0.6	0.4	0.4	7.0	132.3	0.4	0.6	0.3	0.7
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-27.6	-22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	44.4	0.0	27.9	-2.1	0.0	0.0	-0.1	139.7	-1.4	-8.4	-25.8	-1.7	18.4	6.7	7.9	-1.4
Cash from Financing	23.2	0.0	135.3	14.5	0.3	179.7	0.0	112.7	-23.3	-8.0	-23.8	96.0	18.3	7.0	6.1	-0.8

Cash Flow From Financing Activities	3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Debt Repaid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-21.2	0.0	0.0
Debt Issued	34.7	-0.2	1.2	-0.2	-0.2	-0.2	-33.0	32.5	1.9	-93.0
Issuance of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.2
Repurchase of Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Dividends Paid	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Other Financing Activities	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	30.5	-42.6
Cash from Financing	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-21.1	30.5	91.5

Cash position		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Net Change in Cash		-21.1	20.2	-42.8	23.3	-21.0	61.9	0.4	-7.2	-22.7	-25.8	25.3	33.1	3.9	-0.7	-4.7	-0.5
Closing Cash Balance		28.8	51.4	31.2	74.0	50.7	71.7	9.8	9.3	16.6	39.2	65.1	39.8	6.6	2.7	3.5	8.2

Cash position		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Net Change in Cash		16.4	7.0	5.0	22.8	-0.3	-6.9	4.6	-20.6	1.8	-33.4
Closing Cash Balance		79.8	63.4	56.4	51.4	28.6	28.8	35.8	31.2	51.8	50.0

Free Cash Flow		TTM	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Free Cash Flow		-114.0	-46.9	-128.5	-71.0	-77.3	-48.8	-38.4	-102.9	-37.0	17.7	82.7	-12.3	-21.7	-24.2	-12.2	-9.1
Real Free Cash Flow		-131.4	-67.3	-144.3	-78.0	-86.2	-51.8	-38.9	-110.7	-45.1	3.0	74.9	-15.0	-23.7	-27.2	-15.0	-12.2

Free Cash Flow		3-2025	2-2025	1-2025	4-2024	3-2024	2-2024	1-2024	4-2023	3-2023	2-2023
Free Cash Flow		23.2	12.5	-8.2	7.9	-6.9	-18.2	-29.7	-28.0	-38.2	-32.0
Real Free Cash Flow		23.2	7.2	-12.4	3.7	-12.3	-23.6	-35.1	-31.5	-41.4	-39.7

Nacenění

Finance

Efektivita

Marže

Dividenda

Ostatní

Nacenění

Ukazatel	Aktuální	Historické	Konkurence
P/E	-7883.5	-364.8	2356.8
P/S	8.8	27.6	70.5
P/B	22.3	1.1	2015.4
P/FCF	100.7	1.3	7573.5
Market cap	$1.8	$1.0

P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel	Aktuální	Historické	Srovnání
Debt to Assets	18.7 %	35.3 %	0 %
Debt to Income	-13445.3 %	-379 %	0 %
Debt to Free cash flow	171.7 %	-150.5 %	0 %
Interest expense percentage	214.7 %	3 %	26.2 %
Current ratio	2.8	3.8	0